CVS Health Net Worth
CVS Health Net Worth Breakdown | CVS |
CVS Health Net Worth Analysis
CVS Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including CVS Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of CVS Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform CVS Health's net worth analysis. One common approach is to calculate CVS Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares CVS Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing CVS Health's net worth. This approach calculates the present value of CVS Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of CVS Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate CVS Health's net worth. This involves comparing CVS Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into CVS Health's net worth relative to its peers.
Enterprise Value |
|
To determine if CVS Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CVS Health's net worth research are outlined below:
| CVS Health Corp has 79.39 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. CVS Health Corp has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for CVS to invest in growth at high rates of return. | |
| Over 83.0% of CVS Health shares are held by institutions such as insurance companies | |
| On 1st of November 2024 CVS Health paid $ 0.665 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Fmr LLC Reduces Stock Position in CVS Health Co. |
CVS Health Quarterly Good Will |
|
CVS Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CVS Health Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CVS Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know CVS Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as CVS Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CVS Health Corp backward and forwards among themselves. CVS Health's institutional investor refers to the entity that pools money to purchase CVS Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 13.9 M | Pzena Investment Management, Llc | 2024-09-30 | 13.1 M | Franklin Resources Inc | 2024-09-30 | 12.9 M | Charles Schwab Investment Management Inc | 2024-09-30 | 12.2 M | Amvescap Plc. | 2024-06-30 | 12.1 M | Glenview Capital Management Llc | 2024-09-30 | 11.9 M | Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 11.9 M | Northern Trust Corp | 2024-09-30 | 11.6 M | Legal & General Group Plc | 2024-06-30 | 11.4 M | Vanguard Group Inc | 2024-09-30 | 117.6 M | Blackrock Inc | 2024-06-30 | 100.2 M |
Follow CVS Health's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 75.45 B.Market Cap |
|
Project CVS Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.10 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.03 | 0.06 | |
| Return On Equity | 0.11 | 0.12 |
When accessing CVS Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures CVS Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CVS Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in CVS Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CVS Health Corp. Check CVS Health's Beneish M Score to see the likelihood of CVS Health's management manipulating its earnings.
Evaluate CVS Health's management efficiency
CVS Health Corp has Return on Asset of 0.0237 % which means that on every $100 spent on assets, it made $0.0237 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.067 %, implying that it generated $0.067 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVS Health's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.06 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, CVS Health's Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.33 in 2024, whereas Other Assets are likely to drop slightly above 4.8 B in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 59.64 | 62.62 | |
| Tangible Book Value Per Share | (34.14) | (32.43) | |
| Enterprise Value Over EBITDA | 9.50 | 7.58 | |
| Price Book Value Ratio | 1.33 | 1.26 | |
| Enterprise Value Multiple | 9.50 | 7.58 | |
| Price Fair Value | 1.33 | 1.26 | |
| Enterprise Value | 86.8 B | 91.1 B |
The leadership approach at CVS Health's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Enterprise Value Revenue 0.3992 | Revenue 367.2 B | Quarterly Revenue Growth 0.06 | Revenue Per Share 290.198 | Return On Equity 0.067 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CVS Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on CVS Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CVS Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CVS Health Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 15th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 13th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
CVS Health Earnings per Share Projection vs Actual
CVS Health Corporate Directors
| Edward Ludwig | Independent Director | Profile | |
| Mary Schapiro | Independent Director | Profile | |
| Fernando Aguirre | Independent Director | Profile | |
| NancyAnn DeParle | Independent Director | Profile |
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.